Finance

Beta
Lists
AKBA:NASDAQ
Akebia Therapeutics Inc
$0.97
+0.06%
(+0.00060) 1D
$0.97
0.00% (0.00)
After hours
Closed: Jun 4, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AKBA...
Open
$0.97
High
$1.00
Low
$0.96
Mkt. cap
260.21M
Avg. vol.
4.66M
Volume
2.39M
52-wk high
$4.08
52-wk low
$0.88
EPS
-$0.08
Beta
0.26
Shares outstanding
268.26M
No. of employees
194
Open
$0.97
High
$1.00
Low
$0.96
Mkt. cap
260.21M
Avg. vol.
4.66M
Volume
2.39M
52-wk high
$4.08
52-wk low
$0.88
EPS
-$0.08
Beta
0.26
Shares outstanding
268.26M
No. of employees
194
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to AKBA in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AKBA in the last 3 months.
Highest
Current $0.97
$6.00 (+518.37%)
Average
$4.67 (+381.29%)
Lowest
$4.00 (+312.24%)
News stories
From sources across the web
About Akebia Therapeutics Inc
CEO-
Employees194
FoundedJan 1, 2007
HeadquartersCambridge, Massachusetts, United States
SectorBiotechnology
Websiteakebia.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
62.47M
58.77M
57.62M
53.54M
Cost of goods sold
10.72M
10.28M
10.93M
9.78M
Cost of revenue
10.72M
10.28M
10.93M
9.78M
Research and development expenses
11.01M
14.94M
26.65M
14.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.56M
29.09M
26.09M
30.44M
Operating expense
37.57M
44.04M
52.74M
45.24M
Total operating expenses
48.28M
54.32M
63.67M
55.02M
Operating income
14.19M
4.45M
-6.05M
-1.48M
Other non operating income
-7.01M
1.45M
2.14M
459.00K
EBT including unusual items
247.00K
1.16M
-11.24M
-8.93M
EBT excluding unusual items
347.00K
1.16M
-8.73M
-5.71M
Income tax expense
-
615.00K
1.01M
126.00K
Effective tax rate
-
53.25%
-8.98%
-1.41%
Other operating expenses
-
-
-
-
Net income
247.00K
540.00K
-12.24M
-9.05M
Net profit margin
0.40%
0.92%
-21.25%
-16.91%
Earnings per share
0.03
-
-0.05
-0.03
Interest and investment income
-
-
-
-
Interest expense
-6.83M
-4.75M
-4.83M
-4.69M
Net interest expenses
-6.83M
-4.75M
-4.83M
-4.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.50M
4.77M
-5.73M
-1.15M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer